Skip to main content
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD logo

MEDICALSYSTEM BIOTECHNOLOGY CO., LTD — Investor Relations & Filings

Ticker · 300439 ISIN · CNE100001Z25 LEI · 3003007XTAWFVR8ASC23 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300439

About MEDICALSYSTEM BIOTECHNOLOGY CO., LTD

https://www.nbmksw.com

MedicalSystem Biotechnology Co., Ltd. specializes in the research, development, production, and distribution of in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio that includes biochemical reagents, chemiluminescence immunoassay systems, molecular diagnostic kits, and point-of-care testing (POCT) solutions. Its product line covers a wide range of clinical applications such as liver function, kidney function, blood lipids, and cardiovascular markers. MedicalSystem is recognized for its integrated business model, which combines the manufacturing of high-quality diagnostic instruments with a vast array of compatible reagents. Additionally, the company provides third-party medical laboratory services to healthcare institutions. By focusing on technological innovation and standardized production, MedicalSystem supports clinical laboratories in achieving accurate and efficient diagnostic results for improved patient care.

Recent filings

Filing Released Lang Actions
中天国富证券有限公司关于美康生物科技股份有限公司使用部分闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 82% confidence The document is a sponsor’s (保荐机构) verification opinion (“核查意见”) on the use of idle proceeds from a private placement for cash management. It is a compliance verification report, not an annual or interim financial report, not a meeting presentation, call transcript, proxy or dividend notice, nor a notice of share issuance. It contains regulatory compliance content and opinions by the sponsor rather than substantive financial statements. Therefore, it falls under the general regulatory announcements category (RNS).
2026-05-29 Chinese
关于使用部分闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 75% confidence The document is a formal announcement (“公告”) by the company’s board regarding the use of idle proceeds from a prior equity financing (募集资金) for short-term cash management. It outlines the approved board resolution, regulatory compliance, fund amounts, usage plan, risk controls, and sponsor’s opinion. This is not a financial report itself nor a dividend or management change notice, but rather an update on the company’s financing proceeds usage, fitting the Capital/Financing Update category.
2026-05-29 Chinese
第五届董事会第二十次会议决议公告
Board/Management Information Classification · 75% confidence The document is an official announcement of the resolutions passed at the company’s fifth board meeting (board meeting minutes/resolutions). It is not an earnings release, shareholder vote result, nor an annual/interim report. The closest category is Board/Management Information (MANG), covering formal board meeting announcements and resolutions.
2026-05-29 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an official announcement of the resolutions passed at the 2025 Annual General Meeting, detailing the voting results for each proposal, the number of shares voted for, against, and abstained, and compliance statements. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-22 Chinese
北京国枫（杭州）律师事务所关于美康生物科技股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 75% confidence The document is a legal opinion letter issued by a law firm on the legality of the procedures, qualifications of participants, and voting results of the company’s 2025 Annual General Meeting. It is not the AGM materials themselves, nor a direct announcement of the meeting resolutions by the company, nor a management or financial report. It is also not an insider dealing, financing update, or proxy solicitation document. No specific category fits this legal opinion format, so it falls under the fallback category for miscellaneous regulatory filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-22 Chinese
关于召开2025年年度股东会的提示性公告
AGM Information Classification · 90% confidence The document is a formal convocation notice for the company’s 2025 annual general meeting (AGM), detailing meeting date/time, voting procedures, agenda items, proxy form and related attachments. It serves as preparatory AGM information rather than financial statements or a summary of results. Therefore, it should be classified under AGM Information (AGM-R).
2026-05-19 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.